Fresenius SE & Co. (OTCMKTS:FSNUY) Short Interest Up 584.4% in June

Fresenius SE & Co. (OTCMKTS:FSNUY) saw a significant growth in short interest in the month of June. As of June 15th, there was short interest totaling 59,293 shares, a growth of 584.4% from the May 31st total of 8,663 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average daily volume of 412,091 shares, the short-interest ratio is presently 0.1 days.

Wall Street Analyst Weigh In

Separately, Morgan Stanley reaffirmed an “overweight” rating on shares of Fresenius SE & Co. in a report on Tuesday. Three equities research analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company has an average rating of “Buy”.

Fresenius SE & Co. Price Performance

FSNUY traded down $0.07 during trading on Friday, reaching $11.40. The stock had a trading volume of 18,354 shares, compared to its average volume of 123,447. The firm has a market capitalization of $25.68 billion, a price-to-earnings ratio of 15.20 and a beta of 0.64. The company has a quick ratio of 0.98, a current ratio of 1.27 and a debt-to-equity ratio of 0.41. Fresenius SE & Co. has a 1-year low of $10.33 and a 1-year high of $33.93. The stock has a 50 day moving average of $11.54 and a two-hundred day moving average of $13.17.

Fresenius SE & Co. (OTCMKTS:FSNUY) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $0.24 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.01). Fresenius SE & Co. had a net margin of 6.55% and a return on equity of 10.09%. The firm had revenue of $6.75 billion for the quarter, compared to the consensus estimate of $6.79 billion. As a group, equities analysts anticipate that Fresenius SE & Co. will post 1.03 EPS for the current fiscal year.

About Fresenius SE & Co.

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.